111, Inc. (YI)
USD 0.77
(-1.16%)
USD 0.77
(-1.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -160.29 Million CNY | 59.34% |
| 2022 | -394.21 Million CNY | -66.95% |
| 2021 | -236.11 Million CNY | 73.71% |
| 2020 | -897.98 Million CNY | -94.51% |
| 2019 | -461.65 Million CNY | 45.93% |
| 2018 | -853.74 Million CNY | -409.21% |
| 2017 | -167.66 Million CNY | 55.11% |
| 2016 | -373.5 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -249.91 Million CNY | 22.56% |
| 2024 Q1 | -322.73 Million CNY | -101.34% |
| 2023 Q3 | -316.71 Million CNY | -77.85% |
| 2023 FY | -160.29 Million CNY | 59.34% |
| 2023 Q1 | -228.77 Million CNY | 41.97% |
| 2023 Q4 | -160.29 Million CNY | 49.39% |
| 2023 Q2 | -178.07 Million CNY | 22.16% |
| 2022 Q1 | -238.45 Million CNY | -0.99% |
| 2022 Q4 | -394.21 Million CNY | -4.82% |
| 2022 FY | -394.21 Million CNY | -66.95% |
| 2022 Q2 | -278.12 Million CNY | -16.64% |
| 2022 Q3 | -376.06 Million CNY | -35.21% |
| 2021 Q4 | -236.11 Million CNY | 13.21% |
| 2021 FY | -236.11 Million CNY | 73.71% |
| 2021 Q3 | -272.04 Million CNY | 62.59% |
| 2021 Q2 | -727.19 Million CNY | -11.76% |
| 2021 Q1 | -650.64 Million CNY | 27.54% |
| 2020 Q4 | -897.98 Million CNY | -12.29% |
| 2020 Q2 | -499.47 Million CNY | -28.21% |
| 2020 FY | -897.98 Million CNY | -94.51% |
| 2020 Q1 | -389.57 Million CNY | 15.61% |
| 2020 Q3 | -799.72 Million CNY | -60.11% |
| 2019 Q3 | -426.55 Million CNY | 21.93% |
| 2019 Q2 | -546.38 Million CNY | 16.22% |
| 2019 Q1 | -652.16 Million CNY | 23.61% |
| 2019 Q4 | -461.65 Million CNY | -8.23% |
| 2019 FY | -461.65 Million CNY | 45.93% |
| 2018 Q2 | -487.73 Million CNY | -403.33% |
| 2018 FY | -853.74 Million CNY | -409.21% |
| 2018 Q4 | -853.74 Million CNY | 3.02% |
| 2018 Q1 | -96.9 Million CNY | 42.2% |
| 2018 Q3 | -880.32 Million CNY | -80.49% |
| 2017 FY | -167.66 Million CNY | 55.11% |
| 2017 Q1 | 640.32 Million CNY | 0.0% |
| 2017 Q4 | -167.66 Million CNY | 0.0% |
| 2016 FY | -373.5 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | -24345.122% |
| BIMI International Medical Inc. | 3.11 Million USD | 5239.76% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | 1649.365% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 237.69% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 246.941% |
| Leafly Holdings, Inc. | 13.79 Million USD | 1262.224% |
| Leafly Holdings, Inc. | 13.79 Million USD | 1262.224% |
| LifeMD, Inc. | -14.21 Million USD | -1027.69% |
| LifeMD, Inc. | -14.21 Million USD | -1027.69% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | 2405.724% |
| PetMed Express, Inc. | -53.84 Million USD | -197.712% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 101.946% |